Form 13-F position report

HTG MOLECULAR DIAGNOSTICS I

Reported by Squarepoint Ops LLC

HTGM CUSIP 40434H203 Manager CIK 0001642575

Reported 0 shares, down 12,181 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for HTG MOLECULAR DIAGNOSTICS I held by Squarepoint Ops LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2021 Reduced 0 -12,181 (-100.0%) 0 $0 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

27 managers reported HTG MOLECULAR DIAGNOSTICS I for Q3 2021.

Managers reporting HTG MOLECULAR DIAGNOSTICS I in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Cowen Prime Advisors LLC Added 698,533 +128,200 1.48% $3,989,000 2 qtrs
Samjo Capital LLC Added 660,000 +126,000 2.77% $3,769,000 4 qtrs
AIGH Capital Management LLC Unchanged 612,000 0 0.73% $3,494,000 3 qtrs
Nantahala Capital Management LLC Reduced 347,171 -16,451 0.06% $1,982,000 4 qtrs
VANGUARD GROUP INC Added 246,066 +2,741 < 0.01% $1,405,000 4 qtrs
Worth Venture Partners LLC Unchanged 143,135 0 0.37% $817,000 3 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 55,916 -1,200 < 0.01% $319,000 4 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 46,039 -1,099 < 0.01% $262,000 4 qtrs
MILLENNIUM MANAGEMENT LLC New 15,722 +15,722 < 0.01% $90,000 1 qtr
BlackRock Inc Unchanged 15,529 0 < 0.01% $89,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 15, 2021
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.